The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
To find out more about the study, please visit our main site.
Latest blog posts
BSRBR-RA featured on Talking Rheumatology Spotlight podcast!
Prof Kimme Hyrich and Dr Kath Watson from the BSRBR-RA talk to Dr Roz Benson about all things registry, including why the registry was set up, the volume of data (it's big!), publications, high impact papers and ways to get involved. Related ...





Recent Comments